AtriCure (ATRC) EBIT Margin (2010 - 2026)

AtriCure (ATRC) has 17 years of EBIT Margin data on file, last reported at 0.37% in Q1 2026.

• EBIT Margin for Q1 2026 came in at 0.37%, up 519.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.54% (up 676.0% YoY), and the FY2025 annual result was 1.77%, up 683.0% from the prior year.
• EBIT Margin declined to 0.37% in Q1 2026 per ATRC's latest filing, from 1.77% in the prior quarter.
• Over five years, EBIT Margin peaked at 1.77% in Q4 2025 and troughed at 18.97% in Q1 2022.
• A 5-year average of 7.1% and a median of 6.18% in 2023 frame the typical range for EBIT Margin.
• The sharpest annual moves came in 2022 and 2025: EBIT Margin slumped 15292 bps in 2022, then jumped 1346 bps in 2025.
• A 5-year view of EBIT Margin shows it stood at 4.7% in 2022, then sank by 73 bps to 8.14% in 2023, then sank by 44 bps to 11.69% in 2024, then jumped by 115 bps to 1.77% in 2025, then sank by 79 bps to 0.37% in 2026.
• Business Quant data shows ATRC's EBIT Margin at 0.37% in Q1 2026, 1.77% in Q4 2025, and 0.15% in Q3 2025.